Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Abexinostat |
Trade Name | |
Synonyms | PCI-24781|S-78454|CRA-024781 |
Drug Descriptions |
Abexinostat (PCI-24781) is an HDAC inhibitor, which induces tumor cell apoptosis and decreases tumor cell growth (PMID: 16731764, PMID: 25520806). |
DrugClasses | HDAC Inhibitor 45 |
CAS Registry Number | 783355-60-2 |
NCIT ID | C68920 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abexinostat | Abexinostat | 0 | 1 |
Abexinostat + Aldoxorubicin | Abexinostat Aldoxorubicin | 0 | 0 |
Abexinostat + Doxorubicin | Abexinostat Doxorubicin | 0 | 0 |
Abexinostat + Fulvestrant + Palbociclib | Abexinostat Fulvestrant Palbociclib | 0 | 1 |
Abexinostat + Ibrutinib | Abexinostat Ibrutinib | 0 | 1 |
Abexinostat + Pazopanib | Abexinostat Pazopanib | 0 | 1 |
Abexinostat + Pembrolizumab | Abexinostat Pembrolizumab | 0 | 1 |
Abexinostat + Temozolomide | Abexinostat Temozolomide | 0 | 1 |